Alterra.ai & MyMO launches chatbot to answer questions on coronavirus

Alterra.ai & MyMO launches chatbot to answer questions on coronavirus

COVID-19 News –  The COVID Q&A bot answers questions on the coronavirus symptoms, prevention, and treatment, among other things. It helps people concerned about the coronavirus outbreak to quickly get answers to their burning questions.

The bot relies on the information from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). It is available at the developer’s website https://next.alterra.ai/covid-qna-bot and on the Facebook Messenger platform https://m.me/AlterraCovidQnABot.

The bot is available to medical centers, health insurers, government organizations and businesses. Any interested company or organization can customize the bot with its own local or internal information and add it to its website.

For example, as companies switch to remote work as a result of COVID-19 concerns, they can use Alterra’s platform to create custom Q&A bots for their employees to provide answers to quarantine-related questions like work from home policy, suspending international travel, events cancellation, etc. Companies that use Slack can add the COVID Q&A bot to their workspaces, so their employees can get answers right in Slack.

The bot is built on top of a proprietary NLP Engine developed by Alterra.ai,California-based Deep Learning NLP startup, with the help of MyMO, a patient communications and healthcare operations automation company, who brought in its extensive knowledge of the healthcare industry and counts NewYork-Presbyterian, Mount Sinai and several other major hospitals as its customers.


About Alterra.ai
Alterra.ai builds AI that automatically answers questions about companies’ products and instantly resolves repetitive customer issues across channels. Alterra’s products are powered by its proprietary NLP technology which converts natural language questions and commands to formal queries a computer can understand.
https://alterra.ai

Leave a Reply

Your email address will not be published. Required fields are marked *